Trial
NCT00058214
Perifosine in Treating Patients With Recurrent Prostate Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
Adenocarcinoma of the Prostate
Intervention
perifosine
Why stopped
Did not meet interim stopping criteria for continuation to the second stage.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-02-23